Overview of human papillomavirus vaccination policy changes and its impact in the United States: Lessons learned and challenges for the future
- PMID: 33569854
- DOI: 10.1111/phn.12873
Overview of human papillomavirus vaccination policy changes and its impact in the United States: Lessons learned and challenges for the future
Abstract
Background: The HPV vaccination is effective and safe for preventing HPV infection and HPV attributable cancers. Despite this fact, the uptake rate of the vaccination in the United States has remained below the national target of 80%. Health policy focused on allocating resources and creating vaccine-promoting environments can influence HPV vaccination coverage rates. There is a scarcity of information about the HPV vaccination-related health policy and its impact on the outcome of vaccine uptake.
Method: We conducted a comprehensive review of HPV vaccination-related health policies at the federal, state, and professional organization levels and examined their impact on population health by reviewing national data on HPV vaccination uptake rates.
Results: The review revealed that (a) HPV vaccination recommendations, which serve as the federal-level HPV vaccination policy, have changed frequently in terms of gender, age criteria, and dosing schedule, and (b) the frequent changes of the policy have resulted in low uptake rates among male and young adult populations.
Discussion: The uptake rate should be continuously followed to evaluate the impact of recent changes to the federal-level HPV vaccination policy. State-level policies and healthcare professionals, including nurses, are important to the promotion of HPV vaccinations and decreasing HPV vaccination disparities.
Keywords: Papillomavirus vaccine; health policy; immunization; policy implementation; population health.
© 2021 Wiley Periodicals, Inc.
References
REFERENCES
-
- Abiola, S. E., Colgrove, J., & Mello, M. M. (2013). The politics of HPV vaccination policy formation in the United States. Journal of Health Politics, Policy and Law, 38(4), 645-681. https://doi.org/10.1215/03616878-2208567
-
- Alemany, L., Saunier, M., Alvarado-Cabrero, I., Quirós, B., Salmeron, J., Shin, H.-R., Pirog, E. C., Guimerà, N., Hernandez-Suarez, G., Felix, A., Clavero, O., Lloveras, B., Kasamatsu, E., Goodman, M. T., Hernandez, B. Y., Laco, J., Tinoco, L., Geraets, D. T., Lynch, C. F., … de Sanjosé, S. (2015). Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. International Journal of Cancer, 136(1), 98-107. https://doi.org/10.1002/ijc.28963
-
- Ali, H., Guy, R. J., Wand, H., Read, T. R. H., Regan, D. G., Grulich, A. E., Fairley, C. K., & Donovan, B. (2013). Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infectious Diseases, 13, 140. https://doi.org/10.1186/1471-2334-13-140
-
- American Academy of Family Physicians. (2019). Disease- and population-specific immunizations: Human papillomavirus vaccine (HPV). https://www.aafp.org/patient-care/public-health/immunizations/disease-po...
-
- American Cancer Society. (2017). HPV campaign [Video file]. https://www.youtube.com/watch?v=S_nNo_vhMsk&list=PLRu0uHzo7TdJzR83_C...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
